Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: An approach is described for a method, system, and product for generating radial bump patterns. According to some embodiments, the approach includes determining parameters for radial pattern generation in a precomputing phase, creating a radial pattern in a second stage, and generating a layout from the radial pattern in the second stage before manufacture a device embodying the radial pattern. In some embodiments, the radial pattern comprises rings having a number of rows where bump instances are placed and rotated such that they are perpendicular to a radius from a common center line. Furthermore, in some embodiments, the number of rows in a ring is generated pursuant to a set value or dynamically generate based on one or more optimization metrics.

Abstract: The present disclosure relates to a computer-implemented method for use in design for manufacturing associated with a die or package. Embodiments may include providing, using a processor, an electronic design and displaying, at a graphical user interface, at least a portion of a layout associated with the electronic design. Embodiments may also include determining an expected thermal or centrifuge force manufacturing variation associated with the electronic design. Embodiments may further include allowing a user to insert, at the graphical user interface prior to signoff, a copper pillar bump or solder bump on at least a portion of the layout based upon, at least in part, the determined expected thermal or centrifuge force manufacturing variation. Embodiments may further include displaying the copper pillar bump or the solder bump on the layout at the graphical user interface.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives of formula (I) and also compounds of formula (I?) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing novel compounds of the present invention, pharmaceutical compositions comprising compounds of the present invention as an active ingredient as well as the use of compounds of the present invention as a medicament.

Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives of formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives of formula (I) and also compounds of formula (I?) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives of formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: A method for the manufacture of a polycarbonate which comprises reacting a carbonate precursor with a dihydroxy compound in the presence of an aqueous base in an inert organic solvent optionally containing a molecular weight regulator to form an oligomeric polycarbonate, wherein the reaction between the dihydroxy compound and the carbonate precursor is about 80 to about 99% completed; removing the inert organic solvent and the aqueous base to isolate the oligomeric polycarbonate; and transesterifying the isolated oligomeric polycarbonate to form a polymeric polycarbonate at a temperature and pressure effective to remove trace amounts of residual solvent. This method eliminates some of the problems of the prior art such as the removal of solvent from high molecular weight polycarbonate, which is both cumbersome, energy intensive and expensive.

Abstract: A method for the manufacture of bisphenols comprises introducing a combined feed stream comprising a feed stream and a recycle stream into a reactor system comprising at least one reactor containing a catalytic proportion of an acid catalyst and wherein the combined feed stream comprises a carbonyl compound and a stoichiometric excess of phenol; removing from the reactor system a reactor effluent; splitting the reactor effluent into a crystallization feed stream and an effluent recycle stream; extracting from said crystallization feed stream a bisphenol adduct, remainder comprising a mother liquor stream; dehydrating said mother liquor stream and said effluent recycle stream in a dehydrator wherein excess water and carbonyl compound are removed; and recycling the dehydrated mother liquor and the dehydrated effluent recycle stream back to the combined feed stream to effect improved production of p,p-bisphenol, along with increased reactor selectivity and reduced promoter quantities.

Abstract: The invention relates to a modem and a method for providing bit loading computation in a multi-carrier communication system, using a plurality of simultaneous different carriers or tones by measuring the signal to noise ratios (SNRs) for carriers and by determining in dependence of the SNR a related number of bits to be allocated to the respective carrier. The method comprises the steps of providing a sliding window having a frequency width able to contain a predetermined number of the carriers, moving the sliding window over the frequency spectrum of the carriers through a plurality of positions of the window with respect to the carrier frequencies, and when the window contains the predetermined number of the carriers and there is at least one further carrier to be positioned in the window as a new carrier for bit allocation, the window is moved such that on entering a new carrier into the window at one of its borders, a carrier already in the window at the other frequency border leaves the window.

Abstract: A method of precipitating a poly(arylene ether) includes preparing a poly(arylene ether) solution comprising a poly(arylene ether) and a solvent, combining the poly (arylene ether) solution with an antisolvent to form a poly(arylene ether) dispersion comprising a poly(arylene ether) solid, separating the poly(arylene ether) solid from the poly(arylene ether) dispersion to form an isolated poly(arylene ether) solid, determining a particle size distribution of the poly(arylene ether) solid prior to separating the poly(arylene ether) solid from the poly(arylene ether) dispersion, and adjusting a precipitation parameter in response to the particle size distribution. Although the measured particle size distribution is very different from the particle size distribution of the solid poly(arylene ether) ultimately isolated, it is useful for controlling the process. The method may be automated to rapidly adjust precipitation conditions in response to the particle size distribution measurements.

Abstract: A method for the manufacture of bisphenols comprises introducing a combined feed stream comprising a feed stream and a recycle stream into a reactor system comprising at least one reactor containing a catalytic proportion of an acid catalyst and wherein the combined feed stream comprises a carbonyl compound and a stoichiometric excess of phenol; removing from the reactor system a reactor effluent; splitting the reactor effluent into a crystallization feed stream and an effluent recycle stream; extracting from said crystallization feed stream a bisphenol adduct, remainder comprising a mother liquor stream; dehydrating said mother liquor stream and said effluent recycle stream in a dehydrator wherein excess water and carbonyl compound are removed; and recycling the dehydrated mother liquor and the dehydrated effluent recycle stream back to the combined feed stream to effect improved production of p,p-bisphenol, along with increased reactor selectivity and reduced promoter quantities.

Abstract: A method of precipitating a poly(arylene ether) includes preparing a poly(arylene ether) solution comprising a poly(arylene ether) and a solvent, combining the poly (arylene ether) solution with an antisolvent to form a poly(arylene ether) dispersion comprising a poly(arylene ether) solid, separating the poly(arylene ether) solid from the poly(arylene ether) dispersion to form an isolated poly(arylene ether) solid, determining a particle size distribution of the poly(arylene ether) solid prior to separating the poly(arylene ether) solid from the poly(arylene ether) dispersion, and adjusting a precipitation parameter in response to the particle size distribution. Although the measured particle size distribution is very different from the particle size distribution of the solid poly(arylene ether) ultimately isolated, it is useful for controlling the process. The method may be automated to rapidly adjust precipitation conditions in response to the particle size distribution measurements.

Abstract: A method for regenerating deactivated sulfonated cation exchange catalysts comprises washing the deactivated catalyst with phenol-water mixtures comprising about 5-20 wt. % of water in phenol at a temperature of about 70-95° C.

Abstract: A method for the manufacture of bisphenols comprises introducing a combined feed stream comprising a feed stream and a recycle stream into a reactor system comprising at least one reactor containing a catalytic proportion of an acid catalyst and wherein the combined feed stream comprises a carbonyl compound and a stoichiometric excess of phenol; removing from the reactor system a reactor effluent; splitting the reactor effluent into a crystallization feed stream and an effluent recycle stream; extracting from said crystallization feed stream a bisphenol adduct, remainder comprising a mother liquor stream; dehydrating said mother liquor stream and said effluent recycle stream in a dehydrator wherein excess water and carbonyl compound are removed; and recycling the dehydrated mother liquor and the dehydrated effluent recycle stream back to the combined feed stream to effect improved production of p,p-bisphenol, along with increased reactor selectivity and reduced promoter quantities.